Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects, Dixon et al. 2008; request for publication of PR interval data
- PMID: 21564166
- PMCID: PMC3099386
- DOI: 10.1111/j.1365-2125.2010.03856.x
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects, Dixon et al. 2008; request for publication of PR interval data
Comment on
-
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.Br J Clin Pharmacol. 2008 Sep;66(3):396-404. doi: 10.1111/j.1365-2125.2008.03250.x. Epub 2008 Jul 23. Br J Clin Pharmacol. 2008. PMID: 18662287 Free PMC article. Clinical Trial.
References
-
- Lamictal® Summary of Product Characteristics for Lamotrigine. Brentford, London, UK: GlaxoSmithKline; 2009.
-
- Lamictal® (Lamotrigine) Prescribing Information. Research Triangle Park, NC: GlaxoSmithKline; 2009.
-
- Matsuo F, Bergen D, Faught E, Messenheimer JA, Dren AT, Rudd GD, Lineberry CG. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology. 1993;43:2284–91. - PubMed
-
- Saetre E, Abdelnoor M, Amlie JP, Tossebro M, Perucca E, Taubøll E, Anfinsen OG, Isojarvi J, Gjerstad L. Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine. Epilepsia. 2009;50:1841–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
